NTRA Historical PE Ratio Notes

— Natera, Inc. (NTRA) is a leading biotechnology company specializing in cell-free DNA testing, with a focus on non-invasive prenatal testing (NIPT), oncology, & organ health. The company’s innovative genetic tests help guide critical healthcare decisions, serving both patients & healthcare providers. As a high-growth company, Natera has historically reinvested heavily in research & development, supporting expansion into new diagnostic markets. For investors analyzing NTRA’s historical price-to-earnings (PE) ratio, it’s crucial to understand that periods of negative or low earnings may be common, especially in earlier years, as the company prioritized growth over profitability. This often results in a very high or undefined PE ratio, which can appear elevated compared to more mature, consistently profitable companies. Changes in Natera’s PE ratio historically reflect not only stock price fluctuations but also evolving profit margins as the company scales operations & begins generating positive earnings. As such, investors should interpret past PE ratios in the context of Natera’s status as an innovative, rapidly expanding biotech firm rather than judging performance solely by conventional valuation metrics.

On this page we presented the NTRA Historical PE Ratio information for Natera' stock. The average NTRA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 150.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NTRA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NTRA historical PE result, against the recent PE: when this page was posted on 10/5/2026, the most recent closing price for NTRA had been 425.64, and the most recent quarterly earnings result, annualized, was 1.44. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent NTRA PE on 10/5/2026 based on annualized quarterly EPS was 295.6. Based on NTRA's history, that recent PE is elevated relative to the historical average, with the recent PE 96.9% higher than the historical average PE across our data set for Natera.

For self directed investors doing their due diligence on NTRA or any other given stock, valuation analysis for NTRA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Natera PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NTRA. Thanks for visiting, and the next time you need to research NTRA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.